Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes

N Begum1, B Draznin

  • 1Department of Medicine and Research Service, Veterans Affairs Medical Center, Denver, Colorado 80220.

Insights

Diabetes increases glucose transporter 4 (GLUT-4) phosphorylation in adipocytes, impairing insulin-stimulated glucose uptake. Insulin therapy normalizes GLUT-4 function, suggesting a key role for GLUT-4 regulation in diabetic complications.

Area of Science:

  • Molecular biology
  • Cellular metabolism
  • Diabetes research

Background:

  • Glucose transporter 4 (GLUT-4) is crucial for insulin-stimulated glucose uptake in adipocytes.
  • Dysregulation of GLUT-4 contributes to insulin resistance in diabetes.
  • The phosphorylation state of GLUT-4 influences its cellular localization and function.

Purpose of the Study:

  • To investigate the regulation of GLUT-4 phosphorylation in adipocytes from diabetic rats.
  • To elucidate the impact of diabetes on GLUT-4 translocation and dephosphorylation.
  • To explore the role of phosphoserine phosphatase (PSPase) activity in diabetes-induced GLUT-4 alterations.

Main Methods:

  • Isolation of adipocytes from control and streptozotocin-induced diabetic rats.
  • Measurement of GLUT-4 protein content, phosphorylation levels, and 2-deoxyglucose transport.
  • Assay of phosphoserine phosphatase (PSPase) activity using 32P-labeled GLUT-4 and phosphorylase 'a'.

Main Results:

  • Diabetes led to decreased GLUT-4 protein content but increased GLUT-4 phosphorylation.
  • Insulin-stimulated glucose transport and GLUT-4 translocation to plasma membranes were impaired in diabetic adipocytes.
  • Diabetes altered PSPase activity, increasing particulate and decreasing cytosolic fractions, with impaired dephosphorylation of plasma membrane GLUT-4.

Conclusions:

  • Increased GLUT-4 phosphorylation in diabetes is linked to impaired insulin sensitivity.
  • Diabetes disrupts normal GLUT-4 trafficking and dephosphorylation mechanisms.
  • Altered PSPase distribution and activity contribute to the aberrant GLUT-4 phosphorylation observed in diabetic adipocytes.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.